PharmaPoint: Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2025

Published: June 2016
No. of Pages: 476
    ReportsandReports

PharmaPoint: Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2025

Summary

The type 2 diabetes market is mature and crowded with inexpensive generics. Despite being marked by a late-stage pipeline filled with me-too drugs, this market will undergo substantial growth between 2015 and 2025, almost doubling over this period. The main drivers of growth will be the dramatic increase in disease prevalence and physicians’ efforts to delay disease progression and reduce the costly burden of diabetic complications through the use of combination therapies and novel branded drugs. We anticipate that the type 2 diabetes market will experience a shift in the classes of drugs that are preferred by physicians. Rapid uptake of drugs from the glucagon-like peptide-1 receptor agonist (GLP-1RA) class and sodium-glucose co-transporter-2 inhibitor (SGLT-2I) class will occur; while dipeptidyl peptidase-4 inhibitors (DPP-4Is) will continue to grow, but at a much slower rate than previous years. GLP-1RAs and SGLT-2Is will experience the fastest growth of all classes at a CAGR of 12.2% and 13.0% respectively.


Highlights


Key Questions Answered


- Although the T2D market has numerous well-established therapies, it is marked by the presence of a number of unmet needs in current treatments. What are the main unmet needs in this market? Will the drugs under development fulfil the unmet needs of the T2D market?
- The late-stage T2D pipeline is heavily populated with me-too drugs from the classes of GLP-1RAs, DPP-4Is, and SGLT-2Is. Despite this, an oral GLP-1RA formulation and an osmotic pump which delivers subcutaneous exenatide for one year at a time are expected to be game changers in the GLP-1RA class. Both are in Phase III clinical trials and are expected to increase compliance among T2D patients. Will the late-stage drugs make a significant impact on the T2D market? Which of these drugs will have the highest peak sales at the highest CAGR, and why?
- The diagnosed prevalence of T2D in the world skyrocketed in the past 10 years and will continue increasing at the fast pace. How will epidemiological changes impact the growth of the future market?


Key Findings


- The main driver of the enormous expansion of the T2D market will be the dramatic increase in disease prevalence, which is attributable to increased life expectancy and an increasingly sedentary and stressful lifestyle.
- The second largest driver will be the physicians’ efforts to delay disease progression through the use of combination therapies and novel branded drugs.
- With the recent therapeutic guidelines putting emphasis on a patient-tailored approach in treating type 2 diabetes, pharmaceutical companies will achieve considerable success with their me-too drugs.
- In the future, companies will have to shift their focus towards competitive pricing, “niche” drugs aimed at smaller patient groups, and drugs that increase patient compliance (through more convenient administration).
- To date, no drug has demonstrated sustainable efficacy in the treatment of T2D. This unmet need presents a large opportunity for investment by drug developers.

Scope

- Overview of T2D, including epidemiology, etiology, pathophysiology, symptoms, diagnosis, and treatment guidelines.
- Annualized T2D therapeutics market revenue, annual cost of therapy and treatment usage pattern data from 2015 and forecast for ten years to 2025.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs, clinical trial mapping and implications for the T2D therapeutics market.
- Pipeline analysis: comprehensive data split across different phases, emerging novel trends under development, and detailed analysis of late-stage pipeline drugs.
- Analysis of the current and future market competition in the global T2D therapeutics market. Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Reasons to buy

The report will enable you to -
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline. Additionally a list of acquisition targets included in the pipeline product company list.
- Develop business strategies by understanding the trends shaping and driving the global T2D therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global T2D therapeutics market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Track drug sales in the global T2D therapeutics market from 2015-2025.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Published By: GlobalData
Product Code: GlobalData35205


Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and well share relevant market report titles for you to explore.

Related Reports:

  • China Testosterone Propionate Market Research Report 2017

    Notes: Sales, means the sales volume of Testosterone Propionate Revenue, means the sales value of Testosterone Propionate This report studies Testosterone Propionate in China market, focuses on the top players in China market, with capacity, pro...

  • China Dystonia Drug Market Research Report 2017

    Notes: Sales, means the sales volume of Dystonia Drug Revenue, means the sales value of Dystonia Drug This report studies Dystonia Drug in China market, focuses on the top players in China market, with capacity, production, price, revenue and ma...

  • China DHA Soft Capsule Market Research Report 2017

    Notes: Sales, means the sales volume of DHA Soft Capsule Revenue, means the sales value of DHA Soft Capsule This report studies DHA Soft Capsule in China market, focuses on the top players in China market, with capacity, production, price, reven...

  • China DHA Algae Oil Market Research Report 2017

    Notes: Sales, means the sales volume of DHA Algae Oil Revenue, means the sales value of DHA Algae Oil This report studies DHA Algae Oil in China market, focuses on the top players in China market, with capacity, production, price, revenue and ma...

  • China Dermatology Drug Market Research Report 2017

    Notes: Sales, means the sales volume of Dermatology Drug Revenue, means the sales value of Dermatology Drug This report studies Dermatology Drug in China market, focuses on the top players in China market, with capacity, production, price, reven...

  • China Ceramide Market Research Report 2017

    Notes: Sales, means the sales volume of Ceramide Revenue, means the sales value of Ceramide This report studies Ceramide in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for ...

  • China Amlodipine Besylater Market Research Report 2017

    Notes: Sales, means the sales volume of Amlodipine Besylater Revenue, means the sales value of Amlodipine Besylater This report studies Amlodipine Besylater in China market, focuses on the top players in China market, with capacity, production, ...

  • Europe Monoclonal Antibody Market Report 2017

    Notes: Sales, means the sales volume of Monoclonal Antibody Revenue, means the sales value of Monoclonal Antibody This report studies sales (consumption) of Monoclonal Antibody in Europe market, especially in Germany, France, UK, Russia, Italy, ...

  • United States Veterinary/Animal Vaccines Market Report 2017

    Notes: Sales, means the sales volume of Veterinary Animal Vaccines Revenue, means the sales value of Veterinary Animal Vaccines This report studies sales (consumption) of Veterinary Animal Vaccines in United States market, focuses on the top pla...

  • United States Eubiotics Market Report 2017

    Notes: Sales, means the sales volume of Eubiotics Revenue, means the sales value of Eubiotics This report studies sales (consumption) of Eubiotics in United States market, focuses on the top players, with sales, price, revenue and market share f...


Why ReportsnReports.com?

  • 500,000 market research reports and growing.
  • Top Fortune 500 Organizations trust us for research data.
  • 24/7 support on call as well as emails.
  • Your Details are safe with us.
  • Free support for your research requirements.
  • Report Delivery: Email
  • Delivery Time:
    • Upto 24 hrs - working days
    • Upto 48 hrs max - weekends and public holidays

Research Support / Custom Research

If this business study does not have the data and information analysis you need, contact us with your research requirements. We explore available market research reports to map your needs and share report titles with you. Alternatively, we can also offer custom research that suits your budget and timelines. Share your information requirements here.
Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441

Subscription Option

Using our subscription option, you get access to market research reports and industry data of Consumer Goods market as per your needs. Get the best of Consumer Goods research reports by utilizing your research budgets in an optimum way.

More about our Subscription option
Report Alerts

Get Email alerts about market research reports from industries and publishers of your interest: